Please select
your location below

Attenzione, le pagine di questa sezione sono disponibili solo in lingua inglese.

By selecting the International view, you verify that you reside outside of the USA and you wish to view DiaSorin Molecular’s International Product Information. This material is intended for International (non-USA) site visitors only.

Pursuant to the Guidelines of the Ministry of Health dated 28/03/2013 related to health advertising concerning medical devices, in vitro diagnostic medical devices and medical-surgical devices, we hereby inform you that the information contained in this website and to which you are going to access is exclusively intended for professionaloperators.

LIAISON PLEX^® Yeast Blood Culture Assay

Treat in Hours—Not Days

The LIASON PLEX^® Yeast Blood Culture Assay integrates with your standard-of-care workflow for maximum clinical impact through the molecular detection and differentiation of up to 16 pathogens frequently found to cause fungemia.

LIAISON PLEX<sup>®</sup> Yeast Blood Culture Assay

Disease state

Approximately 250,000 U.S. patients are diagnosed with bloodstream infections (BSIs) annually. Sepsis due to a BSI has a mortality rate of 16-40% and delays in appropriate treatment can add additional risk for the patient. Sepsis also has the unfortunate distinction of being the most expensive cause of hospitalization in the U.S. at more than $20B per year.

Fungemia accounts for approximately 10% of all positive blood cultures. Invasive yeast often requires therapeutic adjustments from more generalized empiric therapy.

Fungemia can lead to sepsis, which has a high mortality rate.

The value of LIAISON PLEX^® Yeast Blood Culture Assay

Empower clinicians to rapidly optimize treatment for fungemia.

Clinical impact

Identification of fungi within 2 hours after Gram stain allows for rapid treatment optimization.

Outstanding economic value

Panel selection based on Gram stain helps improve diagnostic stewardship while keeping operational costs under control.

The right assay design

PCR-based molecular chemistry detects 16 yeast pathogens frequently found in fungemia.

How LIAISON PLEX^® Yeast Blood Culture Assay works

The LIAISON PLEX^® Yeast Blood Culture Assay is a syndromic in vitro diagnostic test for the detection and identification of invasive pathogenic yeast. Subculturing is necessary for the identification and susceptibility testing of organisms not detected by the assay.

Transfer sample

Transfer sample to cartridge.

Scan

Scan the Sample ID and the Cartridge ID.

Load and run

Load the cartridge, initiate the Run, and walk away.

Indications for LIAISON PLEX^® Yeast Blood Culture Assay use

Assay and system

An automated, multiplex PCR assay run on the LIAISON PLEX^® System to detect and identify 16 yeast pathogens, including the most relevant pathogen today: Candida auris.

Patient types

Patients with a positive blood culture bottle and Gram stain indicating a fungal organism may be present.

Diagnostic Lab

Hospital, commercial reference, and/or public health laboratories.